Peraza Lisa has filed 7 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 41078 shares of HERON THERAPEUTICS, INC. /DE/ ($HRTX) on January 19, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Peraza Lisa | VP, Chief Accounting Officer | A | Employee Stock Option (Right to Buy) | 41078 | $0.00 | 41,078.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Peraza Lisa | VP, Chief Accounting Officer | A | Restricted Stock Units | 6846 | $0.00 | 6,846.0000 | 0 | 9999.99% | 0.00% |
| Jan. 13, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Peraza Lisa | VP, Chief Accounting Officer | M | Common Stock | 552 | $0.00 | 55,374.0000 | 0 | 1.01% | 0.00% |
| Jan. 13, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Peraza Lisa | VP, Chief Accounting Officer | M | Common Stock | 1289 | $0.00 | 56,663.0000 | 0 | 2.33% | 0.00% |
| Jan. 13, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Peraza Lisa | VP, Chief Accounting Officer | F | Common Stock | 756 | $2.15 | 55,907.0000 | 0 | 1.33% | 0.00% |
| Jan. 13, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Peraza Lisa | VP, Chief Accounting Officer | M | Restricted Stock Units | 552 | $0.00 | 1,656.0000 | 0 | 25.00% | 0.00% |
| Jan. 13, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Peraza Lisa | VP, Chief Accounting Officer | M | Restricted Stock Units | 1289 | $0.00 | 6,675.0000 | 0 | 16.19% | 0.00% |